The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells.
about
A marginal anticancer effect of regorafenib on pancreatic carcinoma cells in vitro, ex vivo, and in vivo.Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma.Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer
P2860
The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The cytotoxic effects of regor ...... human colorectal cancer cells.
@en
The cytotoxic effects of regor ...... human colorectal cancer cells.
@nl
type
label
The cytotoxic effects of regor ...... human colorectal cancer cells.
@en
The cytotoxic effects of regor ...... human colorectal cancer cells.
@nl
prefLabel
The cytotoxic effects of regor ...... human colorectal cancer cells.
@en
The cytotoxic effects of regor ...... human colorectal cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
The cytotoxic effects of regor ...... human colorectal cancer cells.
@en
P2093
Edward Chu
John C Schmitz
Shao-yu Wu
P2860
P304
P356
10.18632/ONCOTARGET.2938
P407
P50
P577
2015-03-01T00:00:00Z